Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DOCS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDOCSDoximity$67.06-0.7%$68.83$40.87▼$85.21$12.56B1.382.14 million shs1.32 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDOCSDoximity-0.80%-6.04%-5.62%+7.57%+59.85%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDOCSDoximity$67.06-0.7%$68.83$40.87▼$85.21$12.56B1.382.14 million shs1.32 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDOCSDoximity-0.80%-6.04%-5.62%+7.57%+59.85%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDOCSDoximity 2.45Hold$69.373.45% UpsideCurrent Analyst Ratings BreakdownLatest MUL, PTD, DOCS, and DTY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/10/2025DOCSDoximityJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral ➝ Underweight$62.0010/8/2025DOCSDoximityEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$75.00 ➝ $81.0010/8/2025DOCSDoximityKeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$75.00 ➝ $80.0010/1/2025DOCSDoximityThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetNeutral ➝ Sell$57.00 ➝ $64.0010/1/2025DOCSDoximityThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral ➝ Sell$57.00 ➝ $64.009/18/2025DOCSDoximityCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$59.00 ➝ $67.009/11/2025DOCSDoximityRobert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$75.00 ➝ $80.009/10/2025DOCSDoximityRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$75.008/20/2025DOCSDoximityZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/11/2025DOCSDoximityPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$65.00 ➝ $69.00(Data available from 10/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDOCSDoximity$589.64M21.30$0.82 per share81.32$5.52 per share12.15Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDOCSDoximity$147.58M$1.1767.0662.674.1036.60%21.75%18.64%N/ALatest MUL, PTD, DOCS, and DTY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025N/ADOCSDoximity$0.31$0.36+$0.05N/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDOCSDoximityN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDOCSDoximityN/A8.748.74Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDOCSDoximity87.19%Insider OwnershipCompanyInsider OwnershipDOCSDoximity31.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDOCSDoximity890187.30 million116.87 millionNot OptionableDOCS HeadlinesRecent News About These CompaniesRegina Benjamin Sells 5,000 Shares of Doximity (NASDAQ:DOCS) Stock3 hours ago | insidertrades.comZoomInfo, Upstart, F5, Procore Technologies, and Doximity Shares Skyrocket, What You Need To KnowOctober 13 at 8:07 PM | msn.comDoximity (DOCS): 3 Reasons We Love This StockOctober 13 at 10:03 AM | finance.yahoo.comDoximity (DOCS) Valuation: Weighing Long-Term Gains Against Recent Share Price DropOctober 11, 2025 | finance.yahoo.comDoximity (NASDAQ:DOCS) Stock Price Down 5% - Should You Sell?October 11, 2025 | marketbeat.comDoximity's (DOCS) Underweight Rating Reiterated at JPMorgan Chase & Co.October 11, 2025 | marketbeat.comDoximity, Inc. $DOCS Shares Sold by Lmcg Investments LLCOctober 11, 2025 | marketbeat.comHere's Why Doximity (DOCS) Fell More Than Broader MarketOctober 10, 2025 | zacks.comDoximity downgraded amid weak digital pharma ad trends and valuation premiumOctober 10, 2025 | investing.comRaymond James Reaffirms Their Buy Rating on Doximity (DOCS)October 10, 2025 | theglobeandmail.comQRG Capital Management Inc. Acquires New Stake in Doximity, Inc. $DOCSOctober 9, 2025 | marketbeat.comEvercore ISI Group Maintains Doximity (DOCS) Outperform RecommendationOctober 9, 2025 | msn.comDoximity, Inc. $DOCS Shares Acquired by Robeco Institutional Asset Management B.V.October 5, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Lowers Stock Holdings in Doximity, Inc. $DOCSOctober 5, 2025 | marketbeat.comFairvoy Private Wealth LLC Acquires 5,436 Shares of Doximity, Inc. $DOCSOctober 4, 2025 | marketbeat.comLecap Asset Management Ltd. Sells 36,278 Shares of Doximity, Inc. $DOCSOctober 4, 2025 | marketbeat.comSynergy Asset Management LLC Invests $18.54 Million in Doximity, Inc. $DOCSOctober 3, 2025 | marketbeat.comCan Doximity's New AI Suite Drive the Growth It Needs?October 2, 2025 | zacks.comDoximity (NASDAQ:DOCS) Downgraded by The Goldman Sachs Group to Strong SellOctober 2, 2025 | marketbeat.comGoldman Sachs Downgrades Doximity (DOCS)October 2, 2025 | msn.comAssessing Doximity: Insights From 12 Financial AnalystsOctober 1, 2025 | benzinga.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDOCS Company DescriptionsDoximity NASDAQ:DOCS$67.06 -0.44 (-0.66%) Closing price 10/14/2025 03:58 PM EasternExtended Trading$67.58 +0.53 (+0.79%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Healthcare Companies Insiders Are Buying NVIDIA Analysts Lift Targets: What It Means for the Stock Price Fastenal Stock Pulls Back in October—Is It Time to Buy FAST? 5 Stocks and ETFs to Weather Volatility as Trade Tensions Rise Why Congress Is Buying Intuitive Surgical Ahead of Earnings D-Wave: Reevaluating the Short Seller’s Case After the Downgrade 3 Dividend Hikes That Signal Renewed Strength in 2025 2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
